Industrially compatible transfusable iPSC-derived RBCs: progress, challenges and prospective solutions

ZR Lim, S Vassilev, YW Leong, JW Hang… - International Journal of …, 2021 - mdpi.com
Amidst the global shortfalls in blood supply, storage limitations of donor blood and the
availability of potential blood substitutes for transfusion applications, society has pivoted …

Living biomaterials to engineer hematopoietic stem cell niches

M Petaroudi, A Rodrigo‐Navarro… - Advanced …, 2022 - Wiley Online Library
Living biointerfaces are a new class of biomaterials combining living cells and polymeric
matrices that can act as biologically active and instructive materials that host and provide …

Extensive immunophenotypic sub-population analysis of StemRegenin1 expanded haematopoietic stem/progenitor cells

J Mellet, CL Hendricks, V Stivaktas, C Durandt… - Stem Cell Research & …, 2024 - Springer
Background Ex vivo haematopoietic stem/progenitor cell (HSPCs) expansion constitutes an
important area of research, and has the potential to improve access to umbilical cord blood …

The monoculture of cord-blood-derived CD34+ cells by an automated, membrane-based dynamic perfusion system with a novel cytokine cocktail

M Jones, A Cunningham, N Frank, D Sethi - Stem Cell Reports, 2022 - cell.com
Human leukocyte antigen (HLA)-matched cord blood (CB) transplantation is a procedure for
the treatment of certain hematological malignancies, hemoglobinopathies, and autoimmune …

Augmented production of platelets from cord blood with euchromatic histone lysine methyltransferase inhibition

Y Liu, J Zhao, Y Wang, P Su, H Wang… - Stem Cells …, 2022 - academic.oup.com
Cord blood hematopoietic stem/progenitor cells (CB-HSPCs) have emerged as a promising
supply for functional platelets to potentially alleviate the increasing demand for platelet …

Further biological characterization of small molecules UM171 and SR1: In vitro effects on three hematopoietic cell populations from human cord blood

P Flores-Guzman, A Torres-Caballero… - Blood Cells, Molecules …, 2025 - Elsevier
Small molecules UM171 and SR1 have already been taken into clinically-oriented protocols
for the ex vivo expansion of hematopoietic stem (HSCs) and progenitor (HPCs) cells. In …

Reducing TGF‐β1 cooperated with StemRegenin 1 promoted the expansion ex vivo of cord blood CD34+ cells by inhibiting AhR signalling

X Zhu, Q Sun, W Tan, H Cai - Cell Proliferation, 2021 - Wiley Online Library
Objective As an inhibitor of the AhR signalling pathway, StemRegenin 1 (SR1) not only
promotes the expansion of CD34+ cells but also increases CD34− cell numbers. These …

Decoding human in vitro terminal erythropoiesis originating from umbilical cord blood mononuclear cells and pluripotent stem cells

X Wang, W Zhang, S Zhao, H Yan, Z Xin, T Cui… - Cell …, 2024 - Wiley Online Library
Ex vivo red blood cell (RBC) production generates unsatisfactory erythroid cells. A deep
exploration into terminally differentiated cells is required to understand the impairments for …

Path of differentiation defines human macrophage identity

K Frenis, B Badalamenti, O Mamigonian, C Weng… - bioRxiv, 2025 - biorxiv.org
Macrophages play central roles in immunity, wound healing, and homeostasis-a functional
diversity that is underpinned by varying developmental origins. The impact of ontogeny on …

[HTML][HTML] 造血干细胞体外扩增及应用研究进展

李清, 郝莎, 程涛 - Chinese Journal of Hematology, 2022 - ncbi.nlm.nih.gov
造血干细胞体外扩增及应用研究进展- PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …